TSW
ACH

Thompson Siegel & Walmsley’s Accendra Health ACH Stock Holding History

Thompson Siegel & Walmsley’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-3,915
Closed -$135K – 881
2017
Q1 		$135K Buy
3,915
+3,812
+3,701% +$136K ﹤0.01% 476
2016
Q4 		$4K Buy
+103
New +$3.48K ﹤0.01% 711
2015
Q2 		– Sell
-30
Closed -$1K – 717
2015
Q1 		$1K Hold
30
– – ﹤0.01% 687
2014
Q4 		$1K Hold
30
– – ﹤0.01% 685
2014
Q3 		$1K Hold
30
– – ﹤0.01% 678
2014
Q2 		$1K Hold
30
– – ﹤0.01% 645
2014
Q1 		$1K Hold
30
– – ﹤0.01% 649
2013
Q4 		$1K Hold
30
– – ﹤0.01% 632
2013
Q3 		$1K Hold
30
– – ﹤0.01% 634
2013
Q2 		$1K Buy
+30
New +$996 ﹤0.01% 653

Other funds holding ACH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Thompson Siegel & Walmsley's ACH Position: Q2 2017 in Review

Thompson Siegel & Walmsley sold out of Accendra Health (ACH) in Q2 2017, closing a stake of 3,915 shares — an estimated $135K sold.

Thompson Siegel & Walmsley first reported a position in ACH in Q2 2013 and held it in 10 quarters. The position peaked at $135K in Q1 2017. 273 funds tracked by Wall St. Rank hold ACH as of Q2 2017.

  • Thompson Siegel & Walmsley reported no remaining Accendra Health position as of Q2 2017 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 3,915 Accendra Health shares in Q2 2017, an estimated $135K.
  • Thompson Siegel & Walmsley first reported a position in Accendra Health in Q2 2013 and held it in 10 quarters.
  • Thompson Siegel & Walmsley's Accendra Health position peaked at $135K in Q1 2017.
  • 273 funds tracked by Wall St. Rank held Accendra Health as of Q2 2017.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2017, filed 9 Aug 2017.